Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 31INDUSTRY 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Melanoma 2Glioblastoma 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostate Adenocarcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Neoplasms 1Gliosarcoma 1Glioma 1Central Nervous System Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Merkel Cell 1Brain Diseases 1Adenocarcinoma 1

Interventions

pembrolizumab 133Gemcitabine 101Paclitaxel 100Carboplatin 84Nivolumab 66Docetaxel 62Bevacizumab 62Cisplatin 57Pemetrexed 50Fluorouracil 49Cyclophosphamide 41Cetuximab 41trametinib 38venetoclax 37Leucovorin 37Irinotecan 37Sorafenib 35Capecitabine 35Ipilimumab 33Dexamethasone 32atezolizumab 31Erlotinib Hydrochloride 28130-nm albumin-bound paclitaxel 28Drug Therapy 27Epoetin Alfa 26Doxorubicin 25Oxaliplatin 24Albumin-Bound Paclitaxel 24Prednisone 23Rituximab 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms × Radiosurgery × Clear all
NCT04365374 2025-10-07

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

GT Medical Technologies, Inc.

Phase 3 Active not recruiting
230 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn
CNS

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡